Classic bipolar illness, as described by Kraepelin 2 and currently reflected in the DSM-IV-TR 3 criteria, is characterized by discrete episodes of mania and depression. However, in 2001, the National Institute of Mental Health Roundtable on prepubertal Bipolar Disorder 4 agreed on 2 different phenotypes in children: "narrow" and "broad." Children with the narrow phenotype have the classic symptoms of episodes of mania and depression, although many of these children experience rapid cycling of their mood states and fail to meet the 4to 7-day criteria for mania, thereby qualifying for a diagnosis of bipolar disorder not otherwise specified (NOS). Children with the broad phenotype present with irritability, mood lability, temper outbursts, hyperactivity, and poor concentration in a nonepisodic illness pattern. To complicate matters, these children frequently fulfill criteria for attention-deficit hyperactivity disorder (ADHD) and can be conceptualized as having ADHD plus affective instability. Other comorbidities are frequently present, further clouding the diagnostic picture.
Two speakers at the November 2006 meeting of the Canadian Academy of Child and Adolescent Psychiatry addressed this controversy. Rakesh Jain 5 proposed a diagnostic approach that first screens for "sensitive" symptoms (that is, irritable mood, distractibility, accelerated speech, and increased energy) and then looks for the "specific" symptoms (that is, elation, grandiosity, flight of ideas, and decreased need for sleep).
Gabrielle Carlson 6 presented a historic review of diagnostic criteria, noting that the "hyperactive child syndrome," a 1960s precursor of the current DSM-IV-TR criteria for ADHD, included criteria of irritability, explosiveness, and sleep problems. She opined that, over the last 30 to 40 years, the criteria for ADHD have been narrowing and the criteria for bipolar disorder have been expanding, which explains the increased use of the diagnosis of bipolar disorder NOS. She argued that children suffering from mania do not grow up to have classic bipolar disorder, although Biederman's group 7 appears to have a different view. Further, she cited Lapalme, 8 who showed that, although children of parents with bipolar disorder have a 5.4% risk of developing bipolar disorder, they have a 52% risk of developing a wide variety of other mental disorders. Therefore, family history in and of itself does not help clarify the diagnostic uncertainties.
To complicate the picture, Thompson, 9 working with an older group of patients, found no prodromal features that clearly distinguished between patients who went on to develop bipolar disorder and those who developed schizophrenia.
With so much diagnostic uncertainty, clinicians are increasingly faced with difficult treatment decisions. Children with the presenting symptoms of ADHD are frequently started on stimulant medications. When there is no response, or prominent mood symptoms are part of the clinical presentation, bipolar disorder is frequently considered, which leads to treatment options of mood stabilizers and (or) atypical antipsychotics-treatments with significant side effect profiles. When used, at least in adult patients, these medications may be prescribed for years, or even a lifetime.
Danielyan and Kowatch 10 have recently produced the most succinct and comprehensive treatment review to date. They note a dramatic increase in the use of medication to treat bipolar disorder in children and conclude that atypical antipsychotics may be more effective than mood stabilizers as first-line interventions.
In summary, bipolar disorders in children remain an area of major controversy. We need new diagnostic criteria specific to children; these are likely to be addressed in the DSM-V. We also need large prospective studies to follow children with bipolar disorder into adulthood. Post and Kowatch 1 have proposed a research strategy to address these troubling issues and cite some practical treatment guidelines.
It is likely that, with general practitioners and pediatricians increasingly providing first-line treatment for ADHD, treatment failures that include children with bipolar disorder will increasingly be referred to psychiatrists and mental health centres.
For interested readers, I have also attached a list of other references, many of which are review articles that speak to these controversies.
In this issue, 2 prominent scientists in this field, Dr Anne Duffy 11 and Dr Kiki Chang, 12 address and debate these controversies.
One final comment: although these controversies have seized the agenda for psychiatrists primarily working with children and youth, bipolar disorder is a spectrum illness extending across all age groups. Children with bipolar disorder will inevitably become adults, and the controversies spawned in childhood will inevitably affect the practice of psychiatrists who primarily treat adults.
